Metabolic Dysfunction-Associated Steatohepatitis |
ChiCTR-IOR-15007206: Effect of yinchen Linggui decoction on NASH based on ultrasonic attenuation parameters |
|
|
| Recruiting | N/A | 72 | | yinchenlinguiji versus yishanfu | Dongfang Hospital, Beijing Univetsity of Chinese Medicine; Level of the institution:, Dongfang Hospital, Beijing Univetsity of Chinese Medicine | Nonalcoholic steatohepatitis | | | | |
ChiCTR-IOR-14005445: Clinical study of Jianpi Liqi Huashi Decoction on insulin resistance and free fatty acid in nonalcoholic steatohepatitis in patients |
|
|
| Not yet recruiting | N/A | 92 | | Jianpi Liqi Huashi decoction ;Placebo (1/10 dosage Jianpi Liqi Huashi decoction) | Infectious Disease Hospital of Pudong New Area Shanghai; Infectious Disease Hospital of Pudong New Area Shanghai, Shanghai Pudong New Area Science and Technology Commission | non-alcoholic steatohepatitis | | | | |
NCT02422238: Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease |
|
|
| Recruiting | N/A | 500 | Europe | | Maastricht University Medical Center, Centrum Obesitas-Eetstoornissen (CO-EUR) | Nonalcoholic Fatty Liver Disease | 12/17 | 12/27 | | |
ChiCTR-INR-16008014: A study of the therapeutic role of baicalin on non-alcoholic steatohepatitis by down-regulating the expression of miR103/107 and its mechanisms |
|
|
| Recruiting | N/A | 240 | | Placebo ;baicalin ;metformin; baicalin plus metformin | the Central Hospital of Qingdao; the Central Hospital of Qingdao, the Central Hospital of Qingdao | non-alcoholic steatohepatitis | | | | |
| Recruiting | N/A | 500 | Europe | quantify the impact of genetic risk factors | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | NASH, HCC, Genetic Predisposition | 01/22 | 12/25 | | |
ChiCTR2100044823: Expanding donor pool for live donor liver transplantation: Utilization of donors with NASH after optimization |
|
|
| Completed | N/A | 410 | | No | not applicable; Level of the institution:, no source of support | live liver donors (LLDs) with and without non-alcoholic steatohepatitis | | | | |
| Recruiting | N/A | 480 | | NA | Shanghai Xinhua Hospital; Sanofi (Beijing) Pharmaceutical Co., Ltd., Sanofi (Beijing) Pharmaceutical Co., Ltd. | Nonalcoholic fatty liver disease | | | | |
NCT06499675: Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study |
|
|
| Completed | N/A | 272 | RoW | sleeve gastrectomy, Liver Biopsy | Egyptian Liver Hospital | Obesity, Obesity, Morbid, Bariatric Surgery Candidate, Steatosis of Liver, Steatohepatitis, Nonalcoholic | 12/23 | 05/24 | | |
| Active, not recruiting | N/A | 600 | Europe | | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | NAFLD, Diabetes, NASH, Fibrosis, Liver, Cirrhosis, Liver, Liver Cancer | 12/35 | 12/35 | | |
ChiCTR1800018629: The combination of diammonium glycyrrhizate enteric capsule and vitamin E can reduce the level of inflammation and degree of liver fibrosis in patients with fatty liver disease |
|
|
| Not yet recruiting | N/A | 200 | | There is no drug treatment, and patients are required to strictly control their diet, formulate a professional diet table and exercise strictly ;Diammonium glycyrrhizate enteric capsule 150mg 3/ d, oral, 12 weeks ;Vitamin E 800mg/d, oral, 12 weeks ;Diammonium glycyrrhizate enteric capsule 150mg 3/ d, oral, 12 weeks , Vitamin E 800mg/d, oral, 12 weeks | First Affiliated Hospital, Jilin University; First Affiliated Hospital, Jilin University, First Affiliated Hospital, Jilin University | non-alcoholic steatohepatitis | | | | |
ChiCTR1800017879: Vitamin D through Banlancing of Gut Microbiota to Improve Non-alcoholic Steatohepatitis (NASH) |
|
|
| Recruiting | N/A | 84 | | Medical treatment+Viamin D: 600,000 IP for the first treatment,and additional 300,000 IU treatment in the following month for total 4 treatments. ;Medical treatment | Public Health and Clinical Center of Chengdu; Public Health and Clinical Center of Chengdu, Liver disease key subjects fund | non-alcoholic steatohepatitis | | | | |
NCT06176079: Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease |
|
|
| Recruiting | N/A | 80 | US | Hyperpolarized (HP) 13C, HP 13C, Hyperpolarized 13C-Urea, HP13C-urea, copol, Magnetic Resonance Imaging, MRI, MR, Saline Flush | Michael Ohliger, MD PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Non Alcoholic Steatohepatitis, NAFLD, NASH | 02/25 | 02/25 | | |
ChiCTR1800015167: Study on the new strategy and key techniques of accurate prevention of nonalcoholic steatohepatitis based on intestinal target bacteria |
|
|
| Recruiting | N/A | 60 | | diet and exercise | Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Project subsidy for Social Development Research Initiative design of Hangzhou City | nonalcoholic steatohepatitis | | | | |
ChiCTR1800016178: Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria |
|
|
| Recruiting | N/A | 120 | | Diet | Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Project subsidy for Social Development Research Initiative design of Hangzhou City | nonalcoholic steatohepatitis | | | | |
NCT04555434: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH |
|
|
| Recruiting | N/A | 120 | RoW | Probiotics, Cellulose (Placebo) | Chuncheon Sacred Heart Hospital | Non-Alcoholic Fatty Liver Disease | 09/20 | 09/20 | | |
NALKOSTEP, NCT02792634: Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery |
|
|
| Recruiting | N/A | 200 | Europe | Sleeve-Gastrectomy, Roux en Y gastric bypass | RWTH Aachen University | Bariatric Surgery Candidate, Nonalcoholic Steatohepatitis, Obesity | 12/20 | 12/22 | | |
ChiCTR1900027262: The Mechanism and Clinical Transformation of heme oxygenase-1 on Mitochondrial function in Non-Alcoholic Steatohepatitis |
|
|
| Recruiting | N/A | 403 | | Liver biopsy ;Liver biopsy ;Collect blood samples | The Third Hospital of Hebei Medical University; The Third Hospital of Hebei Medical University, National Natural Science Foundation of China (Grant No. 81970504 and 8170030286), Natural Science Foundation of Hebei (Grant No. H2018206326 and H2017206282) | Non-Alcoholic Steatohepatitis | | | | |
| Active, not recruiting | N/A | 500 | Europe | Liver biopsy | Catholic University of the Sacred Heart | NASH - Nonalcoholic Steatohepatitis, NAFLD, Obesity, Obesity, Morbid | 01/21 | 01/23 | | |
ChiCTR2000034583: Immune inflammation induced by Treg/Th17 imbalance in nonalcoholic steatohepatitis patients and intervention effect of Jiangzhi Granules |
|
|
| Not yet recruiting | N/A | 32 | | Jiangzhi Granules | Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, National Natural Science Foundation of China | nonalcoholic steatohepatitis | | | | |
ChiCTR1800019456: Continous Versus Intermittent Energy Restriction in the Treatment of Non-diabetic Patients with Nonalcoholic Steatohepatitis in China: A Randomized, Open-label, Controlled Trial |
|
|
| Recruiting | N/A | 20 | | Daily energy intake as 1600-1700kcal for male patients and 1300-1400kcal for female patients combined with Vitamin E soft gel treatment in a dose of 100mg bid,PO. Continue this management 7 days per week for 24 weeks. ;2 days per week with Daily energy intake as 500-600kcal, and the rest 5 days with normal diet(2250kcal/day for male patients and 1800kcal/day for female patients) combined with Vitamin E soft gel treatment in a dose of 100mg bid,PO. Continue this for 24 weeks. | the First Affiliated Hospital of Wenzhou Medical University; the First Affiliated Hospital of Wenzhou Medical University, High Level Creative Talents from Department of Public Health in Zhejiang Province | Non-diabetic Patients with Nonalcoholic Steatohepatitis | | | | |
| Not yet recruiting | N/A | | | | Beijing Ditan Hospital, Capital Medical University; Beijing Municipal Science & Technology Commission, Capital Foundation for Clinical Characteristic Applied Research Projects | Non-alcoholic fatty liver disease | | | | |
| Completed | N/A | 160 | RoW | Evaluation of the degree of fibrosis and steatosis, Screening for the components of metabolic syndrome, Measurement of serum semaphorin concentrations, Identification of semaphorin gene polymorphisms | University Hospital for Infectious Diseases, Croatia, Croatian Science Foundation | Non-Alcoholic Fatty Liver Disease, Immune Response, Biomarkers, Liver Fibrosis, Non Alcoholic Steatohepatitis | 09/21 | 03/22 | | |
KETONASH, NCT06308757: Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis |
|
|
| Recruiting | N/A | 42 | Europe | Very-low-calorie ketogenic diet (VLCKD) with meal replacements, Mediterranean low-calorie diet (LCD) | University of Bologna | NASH, NAFLD, Obesity, Liver Fibrosis | 11/24 | 12/26 | | |
NCT03695796: French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) |
|
|
| Recruiting | N/A | 1000 | Europe | biopsy-proven NAFLD patients with non-invasive tests of liver fibrosis (blood tests, elastography devices) and biobank | University Hospital, Angers | NAFLD | 11/24 | 12/24 | | |
| Recruiting | N/A | 132 | Europe | Blood Sampling, Liver biopsy | University Hospital, Grenoble, Institut National de la Santé Et de la Recherche Médicale, France, Etablissement Français du Sang | HBV, NASH - Nonalcoholic Steatohepatitis | 12/21 | 12/22 | | |
| Not yet recruiting | N/A | | | | West China Hospital of Sichuan University; Tianjin Third Central Hospital, Philips (China) Investment Co. Ltd. | non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatosis hepatitis (NASH) | | | | |
| Completed | N/A | 40 | Europe | Nutritional Intervention | Johannes Gutenberg University Mainz, Goethe University | NASH - Nonalcoholic Steatohepatitis, Diabetes Mellitus, Type 2, Hyperlipidemias | 01/22 | 12/23 | | |
| Recruiting | N/A | 50 | Europe | Ultrasound and Magnetic Resonance | Azienda Unità Sanitaria Locale Reggio Emilia | Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Liver Fibroses | 01/22 | 06/22 | | |
| Completed | N/A | 336 | US | Phase II: Lifestyle treatment, Phase II: Control treatment, Phase I: Observational studies | University of Missouri-Columbia | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity | 03/22 | 04/23 | | |
| Enrolling by invitation | N/A | 30 | RoW | MLCT Oil, LCT Oil (Corn Oil) | National University Hospital, Singapore, Wilmar International | Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, NAFLD | 03/22 | 03/23 | | |
NCT04576923: Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease |
|
|
| Terminated | N/A | 36 | US | Velacur by Sonic Incytes | Indiana University, Sonic Incytes | NAFLD, NASH - Nonalcoholic Steatohepatitis | 04/22 | 04/22 | | |
ADLH, NCT03897218: Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health" |
|
|
| Completed | N/A | 84 | Europe | oatmeal flakes with prebiotic food supplements, millet flakes | RWTH Aachen University | NASH - Nonalcoholic Steatohepatitis | 04/22 | 04/22 | | |
TESLA-NASH, NCT04060368: Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASH |
|
|
| Recruiting | N/A | 30 | Europe | Endoscopic Sleeve Gastroplasty (ESG) with OverStitch® system + Lifestyle modifications, Laparoscopic Sleeve Gastrectomy (LSG) + Lifestyle modifications | Instituto de Investigación Marqués de Valdecilla | Non-alcoholic Steatohepatitis (NASH) | 06/22 | 06/23 | | |
NCT03743272: Repeatability and Reproducibility of Multiparametric MRI |
|
|
| Recruiting | N/A | 61 | Europe | LiverMultiScan, Multiparametric Magnetic Resonance Imaging (mpMRI) | Perspectum | Liver Diseases, Primary Biliary Cirrhosis, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Cirrhosis, Hemochromatosis, Viral Hepatitis, Autoimmune Hepatitis, Primary Sclerosing Cholangitis | 06/22 | 11/22 | | |
| Recruiting | N/A | | | | Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Philips (China) Investment Co. Ltd. | Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatosis hepatitis (NASH) | | | | |
| Recruiting | N/A | 400 | Europe, Japan, US, RoW | Ultrasound application | Tokyo Medical University | Nonalcoholic Steatohepatitis, Ultrasound, Elastography | 07/22 | 07/22 | | |
NCT04341246: Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH) |
|
|
| Completed | N/A | 28 | US | LiverMultiscan, LMS | Perspectum, Food and Drug Administration (FDA) | Non-Alcoholic Fatty Liver Disease | 06/23 | 06/23 | | |
NCT04595474: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes |
|
|
| Active, not recruiting | N/A | 533 | US | Transient Elastography | Joslin Diabetes Center | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fibrosis, Liver, Type 1 Diabetes, Cirrhosis, Liver | 08/22 | 12/24 | | |
NCT03260036: Hepatic Urea Nitrogen Handling in Patients With NASH |
|
|
| Active, not recruiting | N/A | 20 | Europe | | University of Aarhus | Non-Alcoholic Fatty Liver Disease | 08/25 | 08/25 | | |
MRI-Detect, NCT04227782: MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) |
|
|
| Active, not recruiting | N/A | 40 | Europe | Magnetic Resonance Imaging, magnetic resonance spectroscopy, Stable Isotope Study | University of Oxford | Non-Alcoholic Fatty Liver Disease | 10/27 | 10/27 | | |
NCT05052515: The Effects of Natural Extracts Supplementation on NASH Patients |
|
|
| Not yet recruiting | N/A | 50 | NA | Choline - Vitamin C, E and Ampelopsis Grossedentata natural extracts, Placebo | University of Athens, Laikο General Hospital, Athens | NAFLD | 09/22 | 09/22 | | |
NCT04861012: Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt |
|
|
| Not yet recruiting | N/A | 360 | NA | Ultrasound, Fibroscan | Assiut University | Steatohepatitis, Nonalcoholic | 09/22 | 12/22 | | |
NCT05128253: Characterization of the Platelet Inflammatory Response in NAFL and NASH |
|
|
| Recruiting | N/A | 44 | Europe | High fat meal in a subset of patients with NAFL or NASH | Stefania Basili, University of Roma La Sapienza | NASH - Nonalcoholic Steatohepatitis, NAFLD | 09/22 | 08/23 | | |
ChiCTR2000036926: Clinical evaluation of Kuhuang Granules in the treatment of nonalcoholic steatohepatitis |
|
|
| Recruiting | N/A | 160 | | Essentiale combined with Kuhuang Granules placebo ;Essentiale combined with Kuhuang Granules | Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Shenkang Hospital Development Center | nonalcoholic steatohepatitis | | | | |
MASH, NCT04009837: Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain |
|
|
| Completed | N/A | 184 | US | Hip-focused rehabilitation intervention, Spine-focused rehabilitation intervention | University of Delaware, University of Pittsburgh, Duke University, National Institute on Aging (NIA) | Chronic Low-back Pain, Hip Impairments, Hip-spine Syndrome, Osteoarthritis | 10/22 | 10/22 | | |
NCT04682600: The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF |
|
|
| Active, not recruiting | N/A | 164 | US | Liver Incytes System, MRE, MRI PDFF, Fibroscan | Sonic Incytes | Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Liver Fibroses, Liver Steatoses | 11/22 | 07/23 | | |
NCT05015491: Effects of Online App Weight Loss Programs on Liver Health in Obese Adults |
|
|
| Completed | N/A | 39 | US | Noom Healthy Weight Program | Noom Inc., Arizona Liver Health | NASH, Fatty Liver, NAFLD, Weight Loss | 09/22 | 09/22 | | |
NCT05370053: The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology |
|
|
| Recruiting | N/A | 450 | US | ELF Test | University of Kansas Medical Center, Gilead Sciences | Fatty Liver, NAFLD | 12/22 | 12/22 | | |
ChiCTR1900028204: Effect of UDCA on intestinal microecology in patients with non-obese fatty liver disease |
|
|
| Not yet recruiting | N/A | 160 | | UDCA treatment ;placebo ;N/A | Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Zhejiang medical and health research project | nonalcoholic steatohepatitis | | | | |
NCT05037890: Effects of Plant Sterols and Stanols on Liver Inflammation |
|
|
| Recruiting | N/A | 8 | Europe | Margarine | Maastricht University Medical Center, Raisio Group, Unilever R&D, BASF | NASH - Nonalcoholic Steatohepatitis | 12/22 | 12/23 | | |
ChiCTR2000029912: Study for the correlation between cognitive impairment and intestinal flora disorder in patients with nonalcoholic fatty liver disease |
|
|
| Not yet recruiting | N/A | 90 | | 试验组 ;no | Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Zhejiang Province Public Welfare Research Project | nonalcoholic steatohepatitis | | | | |
NCT04783116: Plant Stanols and Liver Inflammation in Overweight and Obese Children |
|
|
| Not yet recruiting | N/A | 52 | Europe | Plant stanols (3g/day), Benecol (Raisio Nutrition Ltd., Raisio, Finland), Placebo | Maastricht University Medical Center | Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Childhood Obesity, Childhood Overweight, Pediatric Obesity | 12/22 | 12/22 | | |
ChiCTR2100044996: A randomized controlled clinical trial of polyethylene glycol losartan in the treatment of nonalcoholic steatohepatitis (NASH) |
|
|
| Recruiting | N/A | 200 | | Glutathione ;Glutathione+polyethylene glycol losartan | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, self-funded | Nonalcoholic fatty liver disease | | | | |
ChiCTR2100046617: A Randomly Controlled Clinical Trial of Electro-acupuncture in Patients with Non-alcoholic Steatohepatitis |
|
|
| Recruiting | N/A | 60 | | Electro-acupuncture ;Minimal-acupuncture | Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-raised | Non-alcoholic steatohepatitis | | | | |
| Completed | N/A | 70 | RoW | Transient elastography, Fibroscan, Tenofovir Disoproxil Fumarate, TDF | Yaşar Bayındır, MD, Nobel Pharmaceuticals | Chronic Hepatitis B, Hepatic Steatosis | 04/23 | 05/24 | | |
Profil-NASH, NCT06152250: Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis |
|
|
| Recruiting | N/A | 40 | Europe | Liver Fine-Needle Aspiration | Hospices Civils de Lyon | Liver Diseases | 01/26 | 01/26 | | |
NCT05044663: Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in NASH Related Compensated Advanced Chronic Liver Disease. |
|
|
| Completed | N/A | 200 | RoW | No intervention | Institute of Liver and Biliary Sciences, India | Chronic Liver Disease | 02/23 | 02/23 | | |
InLi, NCT03915002: Integrated Approaches for Identifying Molecular Targets in Liver Disease |
|
|
| Completed | N/A | 155 | US | | University of Pittsburgh | Alcoholic Liver Disease, Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Steatohepatitis | 04/23 | 04/23 | | |
| Completed | N/A | 29 | Europe | | University Hospital, Gentofte, Copenhagen, Gubra ApS | Non-Alcoholic Fatty Liver Disease, Obesity | 03/23 | 03/23 | | |
EXPLORER, NCT04165343: Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on |
|
|
| Completed | N/A | 81 | US | Positron Emission Tomography (PET) on EXPLORER, PET Scan, Magnetic Resonance Imaging, MRI, Echocardiogram and Electrocardiogram, Echo and EKG or ECG, Blood test, Lab test | University of California, Davis | Non-Alcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH) | 05/23 | 05/23 | | |
NCT05065593: The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis |
|
|
| Active, not recruiting | N/A | 26 | RoW | resistance and aerobic exercise, physical activity recommendation | Hacettepe University | Non-Alcoholic Steatohepatitis | 01/24 | 01/25 | | |
ChiCTR2100052845: Evaluation of Effect of Xiaozhi Hugan Capsule on Non-Alcoholic Steatohepatitis: a Randomized Controlled Trial |
|
|
| Not yet recruiting | N/A | 124 | | Polyene Phosphatidylcholine Capsule ;Xiaozhi Hugan Capsule | The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine; The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine, Special Project of Traditional Chinese Medicine Scientific Research of He'nan Province (No. 2019JDZX2012) | Non-Alcoholic Steatohepatitis | | | | |
ENDONASH, NCT04653311: Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis. |
|
|
| Recruiting | N/A | 100 | Europe | Endomina® | Erasme University Hospital, Epidemiological and Clinical Research Information Network | NASH - Nonalcoholic Steatohepatitis | 06/23 | 12/23 | | |
| Active, not recruiting | N/A | 10 | RoW | NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD). | Universidade Federal do Paraná | Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases, Steatohepatitis | 06/23 | 07/24 | | |
| Terminated | N/A | 175 | US | Esophageal cooling/warming device, EnsoETM, ECD - Esophageal Cooling Device, Mild hypothermia, Normothermia | University of California, San Francisco, University of Colorado, Denver, The Methodist Hospital Research Institute | Cirrhosis, End Stage Liver Disease, Acute Kidney Injury, Liver Transplant; Complications, Chronic Kidney Diseases, Hepatitis c, Hepatitis B, NASH - Nonalcoholic Steatohepatitis, Alcoholic Cirrhosis, Hepatocellular Carcinoma | 08/23 | 09/23 | | |
NCT04820036: A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) |
|
|
| Active, not recruiting | N/A | 20 | US | Insulin Resistance, Quality of Life Assessment, Liver Function Test, Radiologic features of NASH, Serologic features of NASH | Brigham and Women's Hospital, American Society for Gastrointestinal Endoscopy, Boston Scientific Corporation | Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD), Endoscopic Ultrasound, Liver Function, Obesity, Liver Fibroses | 09/24 | 12/24 | | |
| Recruiting | N/A | 260 | Europe | Hepatic evaluation | Assistance Publique - Hôpitaux de Paris, Institute of Cardiometabolism and Nutrition, France | Non-Alcoholic Fatty Liver Disease | 07/23 | 07/24 | | |
| Recruiting | N/A | 700 | Europe | ultrasound, elastography, controlled attenuation parameter (CAP), FLI, FIB-4, NFS | University Hospital, Antwerp | NAFLD, Type 1 Diabetes, Cardiovascular Diseases | 07/23 | 07/25 | | |
NCT04389593: Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference |
|
|
| Recruiting | N/A | 30 | US | | University of California, San Diego | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Liver Fibroses, Liver Inflammation | 08/24 | 08/24 | | |
ChiCTR1900025220: The Association of Gut Microbiota With Nonalcoholic Steatohepatitis in Kashgar. |
|
|
| Not yet recruiting | N/A | 400 | | N/A ;N/A ;N/A ;N/A | Nanhai hospital, Southern Medical University; Nanhai hospital, Southern Medical University, self-raised | Nonalcoholic steatohepatitis | | | | |
| Recruiting | N/A | 1200 | Europe | Blood tests for Single Nucleotide Polymorphisms, Faecal microbiome analysis, Serum for diagnostic biomarkers | Manchester University NHS Foundation Trust, University of Manchester, University of Nottingham, Innovate UK | Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Alcoholic Liver Disease, Liver Fibroses | 04/25 | 04/25 | | |
| Not yet recruiting | N/A | 1000 | NA | Ultrasound liver assessment, Elastography, Ultrasound attenuation, Sound speed | E-Scopics | Liver Diseases, Liver Cirrhosis, NASH - Nonalcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fibrosis, Liver, Steatosis of Liver | 09/23 | 09/23 | | |
NCT05765890: Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey |
|
|
| Completed | N/A | 675 | RoW | No treatment given | Novo Nordisk A/S | Non-alcoholic Steatohepatitis (MASH), Non-alcoholic Fatty Liver Disease (MASLD) | 09/23 | 09/23 | | |
MASH, NCT05630521: Testing Feasibility of Medication Adherence Problem Solving for Hypertension |
|
|
| Active, not recruiting | N/A | 40 | US | Medication Adherence Problem Solving for Hypertension | Rush University Medical Center | Hypertension, Adherence, Medication | 08/24 | 08/24 | | |
NCT04591106: Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE |
|
|
| Enrolling by invitation | N/A | 190 | US | Magnetic resonance imaging (MRI), Magnetic resonance elastography (MRE), Prototype MRE soft flexible passive transducer paddle, MRE transducer paddle | University of California, Los Angeles, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NAFLD, NASH - Nonalcoholic Steatohepatitis | 01/25 | 01/25 | | |
| Active, not recruiting | N/A | 20 | Europe | Formula diet | West German Center of Diabetes and Health | Steatohepatitis, Nonalcoholic | 12/24 | 03/25 | | |
| Recruiting | N/A | 30 | Europe | EVOCs emulsion, Selected-ion flow-tube mass spectrometry (SIFT-MS) | Owlstone Ltd, North Norfolk Primary Care Practices, Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) | Liver Fibrosis, NASH, Liver Diseases | 06/24 | 06/24 | | |
NCT05309642: Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study |
|
|
| Completed | N/A | 72 | RoW | Intermittent calorie restriction, Standard of care | Ewha Womans University Mokdong Hospital | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | 12/23 | 12/23 | | |
NCT05792423: Conditionally Increased Output (CIO) Enhanced Ultrasound System |
|
|
| Completed | N/A | 22 | US | GE ultrasound system with increased acoustic output settings | Massachusetts General Hospital, GE Healthcare | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fatty Liver | 05/24 | 05/24 | | |
| Not yet recruiting | N/A | 450 | RoW | Genomics (DNA Extraction), Epi-genomics, Proteomics (Glycoproteomics), Salivary Metabolomics, Individualized counselling for behavioural modification | National Research Centre, Egypt | Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis | 12/23 | 04/24 | | |
NCT04057287: Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC) |
|
|
| Recruiting | N/A | 670 | RoW | No intervention | Institute of Liver and Biliary Sciences, India | Liver Cirrhoses | 12/23 | 12/23 | | |
NCT05029583: Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D) |
|
|
| Recruiting | N/A | 5000 | Canada | routine screening, physician-driven screening | LMC Diabetes & Endocrinology Ltd. | Nonalcoholic Steatohepatitis, Type 2 Diabetes | 10/25 | 10/25 | | |
ChiCTR2100050145: A large sample, multicenter, randomized controlled trial of Xiaomudan in the treatment of nonalcoholic steatohepatitis (spleen deficiency and phlegm and blood stasis) |
|
|
| Not yet recruiting | N/A | 500 | | Xiaomu pellets ;Polyene phosphatidylcholine | Affiliated Hospital of Shaanxi University of Chinese Medicine; Department of Science and Technology of Shaanxi Province, Department of Science and Technology of Shaanxi Province | Non-alcoholic Steatohepatitis | | | | |
NCT05669677: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease |
|
|
| Active, not recruiting | N/A | 233 | US | | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Chronic or Recovered Hepatitis B, Chronic or Recovered Hepatitis C, Chronic or Recovered Hepatitis D, NAFLD, NASH | 12/26 | 12/26 | | |
NCT05108415: Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test |
|
|
| Not yet recruiting | N/A | 1500 | NA | | HBI Solutions Inc., mProbe Inc. | NAFLD, NASH - Nonalcoholic Steatohepatitis | 12/23 | 12/24 | | |
NCT05165446: Novel MRE Technique to Assess a Risk Factor for Liver Cancer |
|
|
| Active, not recruiting | N/A | 35 | US | | Natalie Torok | NASH - Nonalcoholic Steatohepatitis | 01/24 | 03/24 | | |
ICAN, NCT04781933: Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement |
|
|
| Recruiting | N/A | 60 | Europe | Treatment with Combo, Treatment with placebo | Mativa-Tech SA | NASH - Nonalcoholic Steatohepatitis | 01/24 | 01/25 | | |
NCT06423846: Total Intravenous Anesthesia Versus Inhalation Anesthesia on Postoperative Liver Function |
|
|
| Completed | N/A | 80 | RoW | Total intravenous anesthesia group, TIVA group, sevoflurane group, SEVO group | Benha University | Laparoscopic Sleeve Gastrectomy | 05/24 | 05/24 | | |
NCT06195943: Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis |
|
|
| Recruiting | N/A | 20 | US | Exercise Intervention with use of El-Fit App | Milton S. Hershey Medical Center | NASH - Nonalcoholic Steatohepatitis, NASH, Exercise, Liver | 03/26 | 03/26 | | |
| Completed | N/A | 97 | Europe | Ultrasound Attenuation imaging measurement | Hywel Dda Health Board | Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Non-alcoholic Steatohepatitis, Steatosis of Liver | 04/24 | 04/24 | | |
NCT06193629: A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar |
|
|
| Recruiting | N/A | 150 | RoW | Lang Qingata, placebo | Shupei Li | NASH | 12/24 | 12/24 | | |
NCT06492369: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients |
|
|
| Recruiting | N/A | 380 | RoW | | Tanta University | Metabolic- Associated Fatty Liver Disease (MAFLD) | 10/24 | 11/24 | | |
NCT06338969: The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis |
|
|
| Recruiting | N/A | 150 | RoW | Carbohydrate Restriction after a Gastric Bypass, laparoscopic one anastomotic gastric bypass | The Society of Bariatric and Metabolic Surgeons of Kazakhstan | Obesity, Morbid, NASH, Ketosis, Keto Acidosis, Carbohydrate Metabolism Disorder | 04/25 | 08/25 | | |
NCT04501042: Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery |
|
|
| Recruiting | N/A | 140 | RoW | Bariatric surgery, Liver biopsy, Portal vein sampling | National Taiwan University Hospital, Ministry of Science and Technology, Taiwan | Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Bariatric Surgery | 04/24 | 09/24 | | |
| Completed | N/A | 196 | US | Diagnostic Test, CT Scan, Fibroscan, Urine and Blood testing, HIV Anti-retroviral Background Therapy | Theratechnologies, Dacima Consulting, Medpace, Inc., Vanderbilt University Medical Center, Echosens | HIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis | 10/23 | 10/23 | | |
NCT06354491: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children |
|
|
| Recruiting | N/A | 24 | US | Magnetic Resonance Imaging (MRI), Ultrasound (US) | University of Wisconsin, Madison | NAFLD, NASH | 04/26 | 04/27 | | |
| Enrolling by invitation | N/A | 30 | RoW | Empagliflozin 10 miligrams (mg) | Military University Hospital, Prague | Non-alcoholic Steatohepatitis, Liver Diseases, Diabetes Mellitus, Type 2, Fibrosis, Liver | 12/26 | 12/27 | | |
NCT04054310: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) |
|
|
| Recruiting | N/A | 225 | US | Liver Multi Scan, Biopsy | Perspectum | NASH - Nonalcoholic Steatohepatitis | 05/24 | 05/24 | | |
NCT05507151: Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis |
|
|
| Recruiting | N/A | 30 | US | Endoscopic Sleeve Gastroplasty | West Virginia University | Nonalcoholic Fatty Liver Disease | 05/24 | 05/24 | | |
NCT03674528: Technical Validation of MR Biomarkers of Obesity-Associated NAFLD |
|
|
| Completed | N/A | 152 | US | Magnetic Resonance Elastography (MRE), MRI, Liver biopsy, Intraoperative Biopsy | University of Wisconsin, Madison, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), GE Healthcare, Pfizer, Siemens Medical Solutions, National Center for Advancing Translational Sciences (NCATS) | Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | 06/24 | 06/24 | | |